Literature DB >> 31796949

Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation.

William D Rees1,2, Martin Stahl3, Kevan Jacobson3,2, Brian Bressler1,4, Laura M Sly3,2, Bruce A Vallance3,2, Theodore S Steiner3,2.   

Abstract

BACKGROUND AND AIMS: Endoplasmic reticulum [ER] stress in intestinal epithelial cells [IECs] contributes to the pathogenesis of inflammatory bowel disease [IBD]. We hypothesized that ER stress changes innate signalling in human IECs, augmenting toll-like receptor [TLR] responses and inducing pro-inflammatory changes in underlying dendritic cells [DCs].
METHODS: Caco-2 cells and primary human colon-derived enteroid monolayers were exposed to ATP [control stressor] or thapsigargin [Tg] [ER stress inducer], and were stimulated with the TLR5 agonist flagellin. Cytokine release was measured by an enzyme immunoassay. ER stress markers CHOP, GRP78 and XBP1s/u were measured via quantitative PCR and Western blot. Monocyte-derived DCs [moDCs] were cultured with the IEC supernatants and their activation state was measured. Responses from enteroids derived from IBD patients and healthy control participants were compared.
RESULTS: ER stress enhanced flagellin-induced IL-8 release from Caco-2 cells and enteroids. Moreover, conditioned media activated DCs to become pro-inflammatory, with increased expression of CD80, CD86, MHCII, IL-6, IL-15 and IL-12p70 and decreased expression of CD103 and IL-10. Flagellin-induced IL-8 production correlated with DC activation, suggesting a common stress pathway. Moreover, there were distinct differences in cytokine expression and basal ER stress between IBD and healthy subject-derived enteroid monolayers, suggesting a dysregulated ER stress pathway in IBD-derived enteroids.
CONCLUSIONS: Cellular stress enhances TLR5 responses in IECs, leading to increased DC activation, indicating a previously unknown mechanistic link between epithelial ER stress and immune activation in IBD. Furthermore, dysregulated ER stress may be propagated from the intestinal epithelial stem cell niche in IBD patients.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Colonic enteroids; ER stress; dendritic cells; inflammatory bowel disease

Mesh:

Substances:

Year:  2020        PMID: 31796949     DOI: 10.1093/ecco-jcc/jjz194

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  10 in total

1.  Dietary Tryptophan Supplementation Improves Antioxidant Status and Alleviates Inflammation, Endoplasmic Reticulum Stress, Apoptosis, and Pyroptosis in the Intestine of Piglets after Lipopolysaccharide Challenge.

Authors:  Guangmang Liu; Jingyuan Tao; Jiajia Lu; Gang Jia; Hua Zhao; Xiaoling Chen; Gang Tian; Jingyi Cai; Ruinan Zhang; Jing Wang
Journal:  Antioxidants (Basel)       Date:  2022-04-28

Review 2.  Regenerative Intestinal Stem Cells Induced by Acute and Chronic Injury: The Saving Grace of the Epithelium?

Authors:  William D Rees; Rene Tandun; Enoch Yau; Nicholas C Zachos; Theodore S Steiner
Journal:  Front Cell Dev Biol       Date:  2020-11-12

3.  Interleukin-37 regulates innate immune signaling in human and mouse colonic organoids.

Authors:  Joannie M Allaire; Anita Poon; Shauna M Crowley; Xiao Han; Zohreh Sharafian; Navjit Moore; Martin Stahl; Brian Bressler; Pascal M Lavoie; Kevan Jacobson; Xiaoxia Li; Bruce A Vallance
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

Review 4.  Enteric Viruses and Inflammatory Bowel Disease.

Authors:  Georges Tarris; Alexis de Rougemont; Maëva Charkaoui; Christophe Michiels; Laurent Martin; Gaël Belliot
Journal:  Viruses       Date:  2021-01-13       Impact factor: 5.048

5.  Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation.

Authors:  Bruno Lima Rodrigues; Isabella Dotti; Lívia Bitencourt Pascoal; Joseane Morari; Miriam Esteller; Andressa Coope; Maria de Lourdes Setsuko Ayrizono; Azucena Salas; Raquel Franco Leal
Journal:  Mediators Inflamm       Date:  2022-02-09       Impact factor: 4.711

6.  Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?

Authors:  Yesenia L Franco; Lais Da Silva; Rodrigo Cristofoletti
Journal:  AAPS J       Date:  2021-11-22       Impact factor: 3.603

Review 7.  Endoplasmic Reticulum Stress of Gut Enterocyte and Intestinal Diseases.

Authors:  Han Gao; Chengwei He; Rongxuan Hua; Yuexin Guo; Boya Wang; Chen Liang; Lei Gao; Hongwei Shang; Jing-Dong Xu
Journal:  Front Mol Biosci       Date:  2022-03-24

8.  A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

Authors:  Tirosh Shapira; I Abrrey Monreal; Sébastien P Dion; David W Buchholz; Brian Imbiakha; Andrea D Olmstead; Mason Jager; Antoine Désilets; Guang Gao; Mathias Martins; Thierry Vandal; Connor A H Thompson; Aaleigha Chin; William D Rees; Theodore Steiner; Ivan Robert Nabi; Eric Marsault; Julie Sahler; Diego G Diel; Gerlinde R Van de Walle; Avery August; Gary R Whittaker; Pierre-Luc Boudreault; Richard Leduc; Hector C Aguilar; François Jean
Journal:  Nature       Date:  2022-03-28       Impact factor: 69.504

Review 9.  Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.

Authors:  Xiang-Guang Li; Ming-Xia Chen; Su-Qing Zhao; Xiu-Qi Wang
Journal:  Stem Cell Rev Rep       Date:  2021-06-28       Impact factor: 6.692

10.  A Gut-Ex-Vivo System to Study Gut Inflammation Associated to Inflammatory Bowel Disease (IBD).

Authors:  Mara Gagliardi; Romina Monzani; Nausicaa Clemente; Luca Fusaro; Valentina Saverio; Giovanna Grieco; Elżbieta Pańczyszyn; Nissan Yissachar; Francesca Boccafoschi; Marco Corazzari
Journal:  Biology (Basel)       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.